日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma

癌症相关成纤维细胞通过诱导肺鳞状细胞癌中产生 ROS 的单核细胞 MDSC 来促进免疫抑制

Handan Xiang, Carlo P Ramil #, Josephine Hai #, Chunsheng Zhang, Huijun Wang, Amanda A Watkins, Roshi Afshar, Peter Georgiev, Marc A Sze, Xuelei S Song, Patrick J Curran, Mangeng Cheng, J Richard Miller, Dongyu Sun, Andrey Loboda, Yanlin Jia, Lily Y Moy, An Chi, Philip E Brandish

Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes

溴结构域抑制剂 OTX015/MK-8628 对 ALK 阳性间变性大细胞淋巴瘤的治疗效果:克服耐药表型的替代方法

Michela Boi, Maria Todaro, Valentina Vurchio, Shao Ning Yang, John Moon, Ivo Kwee, Andrea Rinaldi, Heng Pan, Ramona Crescenzo, Mangeng Cheng, Leandro Cerchietti, Olivier Elemento, Maria E Riveiro, Esteban Cvitkovic, Francesco Bertoni, Giorgio Inghirami; AIRC 5xMille Consortium ‘Genetics-Driven Targe

Malignant transformation of CD4+ T lymphocytes mediated by oncogenic kinase NPM/ALK recapitulates IL-2-induced cell signaling and gene expression reprogramming

致癌激酶 NPM/ALK 介导的 CD4+ T 淋巴细胞恶性转化重现 IL-2 诱导的细胞信号传导和基因表达重编程

Michal Marzec, Krzysztof Halasa, Xiaobin Liu, Hong Y Wang, Mangeng Cheng, Donald Baldwin, John W Tobias, Stephen J Schuster, Anders Woetmann, Qian Zhang, Suzanne D Turner, Niels Ødum, Mariusz A Wasik

CEP-32496: a novel orally active BRAF(V600E) inhibitor with selective cellular and in vivo antitumor activity

CEP-32496:一种新型口服 BRAF(V600E)抑制剂,具有选择性细胞和体内抗肿瘤活性

Joyce James, Bruce Ruggeri, Robert C Armstrong, Martin W Rowbottom, Susan Jones-Bolin, Ruwanthi N Gunawardane, Pawel Dobrzanski, Michael F Gardner, Hugh Zhao, Merryl D Cramer, Kathryn Hunter, Ronald R Nepomuceno, Mangeng Cheng, Dana Gitnick, Mehran Yazdanian, Darren E Insko, Mark A Ator, Julius L Ap

The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL

NPM-ALK 增强了 5-氨基咪唑-4-甲酰胺核苷酸甲酰转移酶/IMP 环化水解酶的酶活性:ALK 介导的发病机制和 ALCL 治疗的新见解

Francesco E Boccalatte, Claudia Voena, Chiara Riganti, Amalia Bosia, Lucia D'Amico, Ludovica Riera, Mangeng Cheng, Bruce Ruggeri, Ole N Jensen, Valerie L Goss, Kimberly Lee, Julie Nardone, John Rush, Roberto D Polakiewicz, Michael J Comb, Roberto Chiarle, Giorgio Inghirami

Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes

间变性淋巴瘤激酶特征的功能验证确定 CEBPB 和 BCL2A1 为关键靶基因

Roberto Piva, Elisa Pellegrino, Michela Mattioli, Luca Agnelli, Luigia Lombardi, Francesco Boccalatte, Giulia Costa, Bruce A Ruggeri, Mangeng Cheng, Roberto Chiarle, Giorgio Palestro, Antonino Neri, Giorgio Inghirami